Literature DB >> 22382146

Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma on a 2002-2011 survey.

Sidonie Lambert-Niclot1, Roland Tubiana, Céline Beaudoux, Gilles Lefebvre, Fabienne Caby, Manuela Bonmarchand, Michèle Naouri, Benoit Schubert, Marc Dommergues, Vincent Calvez, Philippe Flandre, Catherine Poirot, Anne-Geneviève Marcelin.   

Abstract

OBJECTIVES: To estimate the frequency of detectable seminal HIV-1 viral load in men with repeatedly undetectable blood viral load, in the recent past years and over a 10-year period (2002-2011) in a large cohort of HIV-1-infected men from couples requesting assisted reproduction technologies. We also searched for an association between HIV-1 RNA seminal viral load, HIV-1 RNA plasma viral load measured by ultrasensitive assay, and blood HIV-1 DNA in a subgroup of 98 patients.
METHODS: Three hundred and four HIV-1 infected men have provided 628 paired blood and semen samples. In a subset of 98 patients for which a blood sample was available, residual viremia, HIV-1 RNA in semen and HIV-1 DNA were studied.
RESULTS: Twenty of 304 patients (6.6%) had detectable HIV-1 RNA in semen, ranging from 135 to 2365 copies/ml, corresponding to 23 samples, although they had concomitantly undetectable HIV-1 RNA in blood while they were under antiretroviral therapy. This prevalence was stable over time even in recent years. There was an association between HIV-1 RNA plasma viral load measured by ultrasensitive assay and HIV-1 DNA in blood, but both were not associated with seminal HIV-1 RNA viral load.
CONCLUSION: It seems cautious individually to maintain the recommendations of safe sex and the recourse to ART, or at least to inform the couple of the residual potential risk, in serodiscordant couples desiring a child.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22382146     DOI: 10.1097/QAD.0b013e328352ae09

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  37 in total

Review 1.  HIV treatment as prevention in men who have sex with men: examining the evidence.

Authors:  Patrick O'Byrne; Paul MacPherson
Journal:  CMAJ       Date:  2015-12-22       Impact factor: 8.262

Review 2.  Measuring the latent reservoir in vivo.

Authors:  Marta Massanella; Douglas D Richman
Journal:  J Clin Invest       Date:  2016-02-01       Impact factor: 14.808

3.  Detection of Simian Immunodeficiency Virus in Semen, Urethra, and Male Reproductive Organs during Efficient Highly Active Antiretroviral Therapy.

Authors:  G Matusali; N Dereuddre-Bosquet; A Le Tortorec; M Moreau; A-P Satie; D Mahé; P Roumaud; O Bourry; N Sylla; S Bernard-Stoecklin; A Pruvost; R Le Grand; N Dejucq-Rainsford
Journal:  J Virol       Date:  2015-04-01       Impact factor: 5.103

4.  Experiences Using Pre-Exposure Prophylaxis for Safer Conception Among HIV Serodiscordant Heterosexual Couples in the United States.

Authors:  Angela R Bazzi; Ashley A Leech; Dea L Biancarelli; Meg Sullivan; Mari-Lynn Drainoni
Journal:  AIDS Patient Care STDS       Date:  2017-07-18       Impact factor: 5.078

5.  A cross-sectional study examining associations between substance use frequency, problematic use and STIs among youth living with HIV.

Authors:  Kristi E Gamarel; Sharon Nichols; Christopher W Kahler; Andrew O Westfall; Michelle A Lally; Craig M Wilson
Journal:  Sex Transm Infect       Date:  2017-11-27       Impact factor: 3.519

Review 6.  Clinical uncertainties, health service challenges, and ethical complexities of HIV "test-and-treat": a systematic review.

Authors:  Sonali P Kulkarni; Kavita R Shah; Karthik V Sarma; Anish P Mahajan
Journal:  Am J Public Health       Date:  2013-04-18       Impact factor: 9.308

Review 7.  Antiretrovirals and safer conception for HIV-serodiscordant couples.

Authors:  Lynn T Matthews; Jennifer A Smit; Susan Cu-Uvin; Deborah Cohan
Journal:  Curr Opin HIV AIDS       Date:  2012-11       Impact factor: 4.283

8.  Analysis of Immunological, Viral, Genetic, and Environmental Factors That Might Be Associated with Decreased Susceptibility to HIV Infection in Serodiscordant Couples in Florianópolis, Southern Brazil.

Authors:  Íris M Santos; Elis A da Rosa; Tiago Gräf; Luiz G E Ferreira; Andrea Petry; Fernanda Cavalheiro; Edna M Reiche; Carlos R Zanetti; Aguinaldo R Pinto
Journal:  AIDS Res Hum Retroviruses       Date:  2015-09-21       Impact factor: 2.205

9.  HIV-1-RNA Decay and Dolutegravir Concentrations in Semen of Patients Starting a First Antiretroviral Regimen.

Authors:  Arkaitz Imaz; Javier Martinez-Picado; Jordi Niubó; Angela D M Kashuba; Elena Ferrer; Dan Ouchi; Craig Sykes; Nerea Rozas; Laura Acerete; Jordi Curto; Antonia Vila; Daniel Podzamczer
Journal:  J Infect Dis       Date:  2016-08-30       Impact factor: 5.226

10.  Emtricitabine seminal plasma and blood plasma population pharmacokinetics in HIV-infected men in the EVARIST ANRS-EP 49 study.

Authors:  Elodie Valade; Jean-Marc Tréluyer; Silvia M Illamola; Naïm Bouazza; Frantz Foissac; Maïlys De Sousa Mendes; Gabrielle Lui; Camille Chenevier-Gobeaux; Marie Suzan-Monti; Christine Rouzioux; Lambert Assoumou; Jean-Paul Viard; Déborah Hirt; Saïk Urien; Jade Ghosn
Journal:  Antimicrob Agents Chemother       Date:  2015-08-17       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.